TrueBlue (TBI) PT Lowered to $13 at BMO Capital
BMO Capital analyst Jeffrey Silber lowered the price target on TrueBlue (NYSE: TBI) to $13.00 (from $15.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
